Both in Pharmaceuticals
TransCode Therapeutics vs Briacell Therapeutics
Over the past year RNAZ returned −86.3% and BCTX returned −73.8%; their daily moves had a correlation of 0.02.
RNAZ −86.3% BCTX −73.8%Growth of $1, one year, split-adjusted
| Metric | RNAZ | BCTX |
|---|---|---|
| Price | $1.74 | $3.50 |
| Market cap | $29.5M | $30.4M |
| Today | +4.19% | −1.69% |
| 1 month | +6.7% | −14.2% |
| 6 months | −79.3% | −12.9% |
| Year to date | −74.5% | −50.8% |
| 1 year | — | −73.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.7M | $22.8M |
| Dividend yield | — | — |
| Volatility (60d) | 76.2% | 75.7% |
| Short % of float | 8.1% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).